The effects of hydrocortisone on systemic arterial blood pressure and urinary protein excretion in dogs

Journal of Veterinary Internal Medicine

Volumn 22, Issue 2, 2008, Pages 273-281

  Schellenberg, S ^a   Mettler, M ^a   Gentilini, F ^b   Portmann, R ^c   Glaus, T M ^a   Reusch, Claudia E ^a,d  

^a VETSUISSE FACULTY UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Albuminuria; Arginine esterase; Hypercortisolism; Hypertension; Proteinuria

Indexed keywords

HYDROCORTISONE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; DRUG EFFECT; FEMALE; HYPERTENSION; MALE; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; BLOOD PRESSURE; DOG DISEASES; DOGS; FEMALE; HYDROCORTISONE; HYPERTENSION; MALE; PROTEINURIA;

ANIMALIA; CANIS FAMILIARIS;

EID: 42449107822     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2007.0039.x     Document Type: Article

References (52)

1. Melby JC. Clinical review. 1: Endocrine hypertension. J Clin Endocrinol Metab 1989;69:697-703.
2. Kelly JJ, Martin A, Whitworth JA. Role of erythropoietin in cortisol-induced hypertension. J Hum Hypertens 2000;14:195-198.
3. Brotman DJ, Girod JP, Posch A, et al. Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. Thromb Res 2006;118:247-252.
4. Ortega TM, Feldman EC, Nelson RW, et al. Systemic arterial blood pressure and urine protein/creatinine ratio in dogs with hyperadrenocorticism. J Am Vet Med Assoc 1996;209:1724-1729.
5. Cowgill LD. Clinical significance, diagnosis, and management of systemic hypertension in dogs and cats. Partners Pract 1991;4:2-3.
6. Martinez NI, Panciera DL, Abbott JA, et al. Evaluation of presser sensitivity to norepinephrine infusion in dogs with iatrogenic hyperadrenocorticism. Presser sensitivity in dogs with hyperadrenocorticism. Res Vet Sci 2005;78:25-31.
7. Hurley KJ, Vaden SL. Evaluation of urine protein content in dogs with pituitary-dependent hyperadrenocorticism. J Am Vet Med Assoc 1998;212:369-373.
8. Waters CB, Adams LG, Scott-Moncrieff JC, et al. Effects of glucocorticoid therapy on urine protein-to-creatinine ratios and renal morphology in dogs. J Vet Intern Med 1997;11:172-177.
9. Feldman EC, Nelson RW. Canine and Feline Endocrinology and Reproduction, 3rd ed. St Louis, MO: WB Saunders; 2004:253-264.
10. Wenger M, Sieber-Ruckstuhl NS, Muller C, et al. Effect of trilostane on serum concentrations of aldosterone, Cortisol, and potassium in dogs with pituitary-dependent hyperadrenocorticism. Am J Vet Res 2004;65:1245-1250.
11. Vincent IC, Michell AR, Leahy RA. Non-invasive measurement of arterial blood pressure in dogs: A potential indicator for the identification of stress. Res Vet Sci 1993;54:195-201.
12. Gentilini F, Dondi F, Mastrorilli C, et al. Validation of a human immunoturbidimetric assay to measure canine albumin in urine and cerebrospinal fluid. J Vet Diagn Invest 2005;17:179-183.
13. Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation. Am J Kidney Dis 1999;33:1004-1010.
14. Le Bricon T, Erlich D, Bengoufa D, et al. Sodium dodecyl sulfate-agarose gel electrophoresis of urinary proteins: Application to multiple myeloma. Clin Chem 1998;44:1191-1197.
15. Perkins DN, Pappin DJ, Creasy DM, et al. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20:3551-3567.
16. Lees GE, Brown SA, Elliott J, et al. Assessment and management of proteinuria in dogs and cats: 2004 ACVIM forum consensus statement (small animal). J Vet Int Med 2005;19:377-385.
17. Chin-Dusting JP, Ahlers BA, Kaye DM, et al. L-arginine transport in humans with cortisol-induced hypertension. Hypertension 2003;41:1336-1340.
18. Goy-Thollot I, Pechereau D, Keroack S, et al. Investigation of the role of aldosterone in hypertension associated with spontaneous pituitary-dependent hyperadrenocorticism in dogs. J Small Anim Pract 2002;43:489-492.
19. Stepien RL, Rapoport GS, Henik RA, et al. Comparative diagnostic test characteristics of oscillometric and Doppler ultrasonographic methods in the detection of systolic hypertension in dogs. J Vet Intern Med 2003;17:65-72.
20. Brown S, Atkins C, Bagley R, et al. Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med 2007;21:542-558.
21. Behrend EN, Kemppainen RJ, Boozer AL, et al. Serum 17-alpha- hydroxyprogesterone and corticosterone concentrations in dogs with nonadrenal neoplasia and dogs with suspected hyperadrenocorticism. J Am Vet Med Assoc 2005;227:1762-1767.
22. Sieber-Ruckstuhl NS, Boretti FS, Wenger M, et al. Evaluation of different cortisol precursors in dogs with pituitary-dependent hyperadrenocorticism and in healthy dogs. Vet Rec, in press.
23. Rijnberk A, Kooistra HS, van Vonderen IK, et al. Aldosteronoma in a dog with polyuria as the leading symptom. Domest Anim Endocrinol 2001;20:227-240.
24. Connell JM, Jamieson AJ, Davies E, et al. 11 Beta-hydroxylase activity in glucocorticoid suppressible hyperaldosteronism: Lessons for essential hypertension? Endocr Res 1996;22:691-700.
25. Remillard RL, Ross JN, Eddy JB. Variance of indirect blood pressure measurements and prevalence of hypertension in clinically normal dogs. Am J Vet Res 1991;52:561-565.
26. Schellenberg S, Glaus TM, Reusch CE. The effect of adaptation over multiple days on indirect blood pressure measurement in conscious and untrained beagle dogs. Vet Rec 2007;161:418-421.
27. Bodey AR, Michell AR. Epidemiological study of blood pressure in domestic dogs. J Small Anim Pract 1996;37:116-125.
28. Hanson JM, Kooistra HS, Mol JA, Teske E, Meij BP. Plasma profiles of adrenocorticotropic hormone, cortisol, alpha-melanocyte-stimulating hormone, and growth hormone in dogs with pituitary-dependent hyperadrenocorticism before and after hypophysectomy. J Endocrinol 2006;190:601-609.
29. Silva CM, Powell-Oliver FE, Jewell CM, et al. Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 1994;59:436-442.
30. Knutsson U, Stierna P, Marcus C, et al. Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function. J Endocrinol 1995;144:301-310.
31. Dong Y, Poellinger L, Gustafsson JA, et al. Regulation of glucocorticoid receptor expression: Evidence for transcriptional and posttranslational mechanisms. Mol Endocrinol 1988;2:1256-1264.
32. Burnstein KL, Bellingham DL, Jewell CM, et al. Autoregulation of glucocorticoid receptor gene expression. Steroids 1991:56:52-58.
33. Huizenga NA, De Herder WW, Koper JW, et al. Decreased ligand affinity rather than glucocorticoid receptor down-regulation in patients with endogenous Cushing's syndrome. Eur J Endocrinol 2000;142:472-476.
34. Miki K, Morimoto T, Nose H, et al. Canine blood volume and cardiovascular function during hyperthermia. J Appl Physiol 1983;55:300-306.
35. Etxabe J, Vazquez JA. Morbidity and mortality in Cushing's disease: An epidemiological approach. Clin Endocrinol (Oxford) 1994;40:479-484.
36. Baid S, Nieman LK. Glucocorticoid excess and hypertension. Curr Hypertens Rep 2004;6:493-499.
37. Sapienza P, Cavallaro A. Persistent hypertension after removal of adrenal tumours. Eur J Surg 1999;165:187-192.
38. Baas JJ, Schaeffer F, Joles JA. The influence of cortisol excess on kidney function in the dog. Vet Q 1984;6:17-21.
39. Hall JE, Morse CL, Smith MJ, et al. Control of arterial pressure and renal function during glucocorticoid excess in dogs. Hypertension 1980;2:139-148.
40. Kubota E, Hayashi K, Matsuda H, et al. Role of intrarenal angiotensin II in glucocorticoid-induced renal vasodilation. Clin Exp Nephrol 2001;5:186-192.
41. Koh JM, Kim JY, Chung YE, et al. Increased urinary albumin excretion in Cushing's syndrome: Remission after correction of hypercortisolaemia. Clin Endocrinol (Oxford) 2000;52:349-353.
42. Gary AT, Cohn LA, Kerl ME, et al. The effects of exercise on urinary albumin excretion in dogs. J Vet Intern Med 2004;18:52-55.
43. Dyer AR, Greenland P, Elliott P, et al. Evaluation of measures of urinary albumin excretion in epidemiologic studies. Am J Epidemiol 2004;160:1122-1131.
44. Hansen HP, Hovind P, Jensen BR, et al. Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy. Kidney Int 2002;61:163-168.
45. van Acker BA, Stroomer MK, Gosselink MA, et al. Urinary protein excretion in normal individuals: Diurnal changes, influence of orthostasis and relationship to the renin-angiotensin system. Contrib Nephrol 1993;101:143-150.
46. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, et al. Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals. J Hum Hypertens 1997;11:727-732.
47. Bigazzi R, Bianchi S, Baldari D, et al. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 1998;16:1325-1333.
48. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988;2:530-533.
49. Kuusisto J, Mykkanen L, Pyorala K, et al. Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease. Circulation 1995;91:831-837.
50. Chapdelaine P, Dube JY, Frenette G, et al. Identification of arginine esterase as the major androgen-dependent protein secreted by dog prostate and preliminary molecular characterization in seminal plasma. J Androl 1984;5:206-210.
51. Isaacs WB, Coffey DS. The predominant protein of canine seminal plasma is an enzyme. J Biol Chem 1984;259:11520-11526.
52. Bonfanti U, Zini E, Minetti E, et al. Free light-chain proteinuria and normal renal histopathology and function in 11 dogs exposed to Lleishmania infantum, Ehrlichia canis, and Babesia canis. J Vet Intern Med 2004;18:618-624.